Inventor · disambiguated record
Christopher Mehlin
Also filed as: MEHLIN CHRISTOPHER
29 granted patents·26 pending applications·702 citations·filing 2007–2025
98Inventor score
Files withAMGEN INC21HUTCHINSON FRED CANCER RES8JACKSON SIMON MARK8AMGEN K A INC4FRED HUTCHINSON CANCER CENTER4
Top patents by PatentIndex Score
55 records- 0199US8859741B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 14, 2014·51 cites·24 claims
- 0299US8829165B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2013·Granted Sep 9, 2014·76 cites·29 claims
- 0398US8883983B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 11, 2014·26 cites·30 claims
- 0498US8871914B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·25 claims
- 0598US8871913B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·29 claims
- 0698US8563698B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2009·Granted Oct 22, 2013·72 cites·6 claims
- 0798US7767206B2Neutralizing determinants of IL-17 Receptor A and antibodies that bind theretoAMGEN INC·Filed 2007·Granted Aug 3, 2010·76 cites·8 claims
- 0897US9056915B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Jun 16, 2015·20 cites·23 claims
- 0997US9045547B2Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted Jun 2, 2015·42 cites·66 claims
- 1097US8981064B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Mar 17, 2015·20 cites·29 claims
- 1197US8889834B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 18, 2014·25 cites·20 claims
- 1297US7982016B2Antigen binding proteins capable of binding thymic stromal lymphopoietinAMGEN INC·Filed 2008·Granted Jul 19, 2011·130 cites·16 claims
- 1396US8790648B2Methods of treating psoriasis using IL-17 receptor A antibodiesTOCKER JOEL·Filed 2012·Granted Jul 29, 2014·27 cites·59 claims
- 1494US9073999B2Anti-IL-17 receptor A neutralizing antibodiesTOCKER JOEL·Filed 2010·Granted Jul 7, 2015·16 cites·4 claims
- 1592US9920134B2Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted Mar 20, 2018·13 cites·17 claims
- 1690US9315577B2Anti-hepcidin antibodies and methods of useFOLTZ IAN·Filed 2009·Granted Apr 19, 2016·24 cites·2 claims
- 1789US2024294652A1Il-17 receptor a antigen binding proteinsAMGEN K A INC·Filed 2023·Application pending·0 cites
- 1888US11090358B2Cartilage-homing peptidesHUTCHINSON FRED CANCER RES·Filed 2016·Granted Aug 17, 2021·4 cites·27 claims
- 1988US10287348B2Antigen binding proteins capable of binding thymic stromal lymphopoietinAMGEN INC·Filed 2016·Granted May 14, 2019·6 cites·12 claims
- 2088US10208122B2IL-17 receptor A antigen binding proteinsAMGEN K A INC·Filed 2016·Granted Feb 19, 2019·4 cites·5 claims
- 2185US9493576B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 15, 2016·2 cites·43 claims
- 2284US9284372B2Antigen binding proteins capable of binding thymic stromal lymphopoietinCOMEAU MICHAEL R·Filed 2012·Granted Mar 15, 2016·6 cites·7 claims
- 2384US8163284B2Methods of treating TSLP-related inflammatory disordersCOMEAU MICHAEL R·Filed 2011·Granted Apr 24, 2012·7 cites·14 claims
- 2477US10156559B2Lipocalin fusion partnersHUTCHINSON FRED CANCER RES·Filed 2013·Granted Dec 18, 2018·3 cites·22 claims
- 2576US2025154241A1Antigen binding proteins capable of binding thymic stromal lymphopoietinAMGEN INC·Filed 2025·Application pending·0 cites
- 2675US11858999B2IL-17 receptor A antigen binding proteinsAMGEN K A INC·Filed 2020·Granted Jan 2, 2024·0 cites·4 claims
- 2773US11180564B2IL-17 Receptor A antigen binding proteinsAMGEN K A INC·Filed 2018·Granted Nov 23, 2021·0 cites·3 claims
- 2872US2015031870A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2014·Application pending·0 cites
- 2972US2023364183A1Cartilage-homing peptidesFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 3071US11648290B2Cartilage-homing peptidesFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted May 16, 2023·0 cites·20 claims
- 3171US2015087819A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2014·Application pending·0 cites
- 3270US2024294663A1Anti-mesothelin antigen-binding molecules and uses thereofLINK ASSIGNMENT FOR THE BENEFIT OF CREDITORS LLC·Filed 2024·Application pending·0 cites
- 3370US2025034250A1Anti-cd33 antibodies and uses thereofFred Hutchison Cancer Center·Filed 2024·Application pending·0 cites
- 3468US2014356355A1Il-17 receptor a antigen binding proteinsAMGEN INC·Filed 2014·Application pending·0 cites
- 3567US2010028345A1Il-17 receptor a antigen binding proteinsAMGEN INC·Filed 2007·Application pending·0 cites
- 3666US11981745B2Anti-mesothelin antigen-binding molecules and uses thereofLINK IMMUNOTHERAPEUTICS INC·Filed 2023·Granted May 14, 2024·0 cites·26 claims
- 3766US2013058944A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2012·Application pending·0 cites
- 3866US2020071393A1Antigen Binding Proteins Capable of Binding Thymic Stromal LymphopoietinAMGEN INC·Filed 2019·Application pending·0 cites
- 3965US2013079501A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 4065US2012213797A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 4165US2013052201A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2012·Application pending·0 cites
- 4265US2012251544A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 4365US2013085265A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 4462US2011027287A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2010·Application pending·0 cites
- 4557US12116406B2Anti-CD33 antibodies and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Oct 15, 2024·0 cites·11 claims
- 4657US11987640B2Anti-mesothelin antigen-binding molecules and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted May 21, 2024·0 cites·12 claims
- 4750US2019101528A1Lipocalin fusion partnersHUTCHINSON FRED CANCER RES·Filed 2018·Application pending·0 cites
- 4849US2021252159A1Conjugates of cartilage-homing peptidesHUTCHINSON FRED CANCER RES·Filed 2019·Application pending·0 cites
- 4946US2008124340A1Erythropoietin receptor agonistsBORGES LUIS G·Filed 2007·Application pending·0 cites
- 5044US2020262877A1Ion channel-binding peptides and methods of use thereofBLAZE BIOSCIENCE INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Christopher Mehlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →